Halliburton Co: Form 10-Q for the period ended Jun 30, 2017
Filed with the SEC on Jul 28, 2017 and accepted by EDGAR at Jul 28, 2017, 14:05 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2017-04-01 to 2017-06-30 | $4.96bn | us-gaap:SalesRevenueNet |
| Revenue | 6 months2017-01-01 to 2017-06-30 | $9.24bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2017-04-01 to 2017-06-30 | $1.02bn | us-gaap:CostOfGoodsSold |
| Cost of revenue | 6 months2017-01-01 to 2017-06-30 | $1.94bn | us-gaap:CostOfGoodsSold |
| Operating income | 3 months2017-04-01 to 2017-06-30 | $146.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2017-01-01 to 2017-06-30 | $349.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2017-04-01 to 2017-06-30 | −$29.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2017-01-01 to 2017-06-30 | −$54.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2017-04-01 to 2017-06-30 | $28.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2017-01-01 to 2017-06-30 | −$4.0m | us-gaap:NetIncomeLoss |
| Diluted shares (weighted) | 3 months2017-04-01 to 2017-06-30 | 871,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2017-01-01 to 2017-06-30 | 868,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2017-01-01 to 2017-06-30 | $351.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2017-01-01 to 2017-06-30 | $592.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 6 months2017-01-01 to 2017-06-30 | $312.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2017-06-30 | $2.14bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-06-30 | $10.26bn | us-gaap:AssetsCurrent |
| Total assets | At period end2017-06-30 | $25.32bn | us-gaap:Assets |
| Current liabilities | At period end2017-06-30 | $4.07bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2017-06-30 | $16.37bn | us-gaap:Liabilities |
| Long-term debt | At period end2017-06-30 | $10.82bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2017-06-30 | $336.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2017-06-30 | $8.92bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000045012-17-000159. Last ingested by Listed: Nov 2, 2026, 13:24 ET. Listed shows no prices and gives no investment advice.